CAPTIVATE: Fixed-duration first-line treatment with ibrutinib plus venetoclax for CLL/SLL ecancer 11:23 3 years ago 92 Далее Скачать
CAPTIVATE: First-line ibrutinib plus venetoclax for CLL/SLL ecancer 10:41 3 years ago 298 Далее Скачать
CAPTIVATE: fixed-duration ibrutinib plus venetoclax in patients with CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 3 years ago 175 Далее Скачать
Ibrutinib plus venetoclax for the first-line treatment of CLL/SLL: Results from the CAPTIVATE study ecancer 4:04 4 years ago 175 Далее Скачать
Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:43 1 year ago 621 Далее Скачать
Update on fixed-duration cohort of CAPTIVATE trial for CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 2:27 3 years ago 216 Далее Скачать
Fixed-duration ibrutinib and venetoclax for first-line CLL ecancer 7:36 3 years ago 123 Далее Скачать
Ibrutinib + venetoclax for first-line treatment of chronic lymphocytic leukaemia (CLL)/small lym... ecancer 6:47 2 years ago 90 Далее Скачать
Ibrutinib plus Venetoclax for first-line treatment of chronic lymphocytic leukaemia ecancer 6:55 3 years ago 377 Далее Скачать
Positive Long-Term Data of Ibrutinib + Venetoclax as First-Line CLL Treatment CheckRare 4:12 2 years ago 264 Далее Скачать
Ibrutinib Plus Venetoclax for Treatment of CLL (Chronic Lymphocytic Leukemia) - ASCO 2022 CLL Society 6:14 1 year ago 63 Далее Скачать
The future of fixed-duration therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 127 Далее Скачать
Ibrutinib plus venetoclax for first-line treatment of CLL: 4-year follow-up data VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 485 Далее Скачать
CAPTIVATE: 1-year DFS results from the MRD cohort in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:17 4 years ago 106 Далее Скачать
Long Term Follow-Up With Ibrutinib + Venetoclax to Treat Chronic Lymphocytic Leukemia CheckRare 5:29 1 year ago 806 Далее Скачать
Frontline ibrutinib + venetoclax in CLL: Results from a fixed duration cohort of the CAPTIVATE study Lymphoma Hub 4:45 3 years ago 108 Далее Скачать
Support Shown for Fixed-Duration Combination Ibrutinib + Venetoclax for CLL Patients CheckRare 4:46 4 years ago 94 Далее Скачать
CAPTIVATE study: outcomes in patients with uMRD following cessation of ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 1:34 1 year ago 107 Далее Скачать
5-year follow-up of patients with CLL treated in first-line with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 1:13 1 year ago 436 Далее Скачать
First-line ibrutinib and venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:18 2 years ago 350 Далее Скачать
